Healthcare provider profile · identity verified

Marla Vance, M.D.

Family Practice · REED CITY, MI · NPI 1437141330

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	405	91
Atorvastatin Calcium	Atorvastatin Calcium	354	102
Amlodipine Besylate	Amlodipine Besylate	294	80
Omeprazole	Omeprazole	252	80
Gabapentin	Gabapentin	235	69
Losartan Potassium	Losartan Potassium	210	57
Lisinopril	Lisinopril	190	46
Sertraline Hcl	Sertraline Hcl	151	41
Rosuvastatin Calcium	Rosuvastatin Calcium	129	39
Potassium Chloride	Potassium Chloride	116	33
Albuterol Sulfate Hfa	Albuterol Sulfate	115	37
Metoprolol Succinate	Metoprolol Succinate	111	32
Hydrochlorothiazide	Hydrochlorothiazide	106	32
Metformin Hcl	Metformin Hcl	103	27
Pantoprazole Sodium	Pantoprazole Sodium	103	26
Prednisone	Prednisone	103	76
Trulicity	Dulaglutide	101	16
Simvastatin	Simvastatin	98	31
Trazodone Hcl	Trazodone Hcl	94	20
Eliquis	Apixaban	88	19
Allopurinol	Allopurinol	87	20
Metoprolol Tartrate	Metoprolol Tartrate	86	22
Furosemide	Furosemide	79	22
Montelukast Sodium	Montelukast Sodium	79	12
Alendronate Sodium	Alendronate Sodium	78	21
Duloxetine Hcl	Duloxetine Hcl	77	19
Metformin Hcl Er	Metformin Hcl	73	21
Tramadol Hcl	Tramadol Hcl	70	12
Pravastatin Sodium	Pravastatin Sodium	61	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	20
Doxycycline Monohydrate	Doxycycline Monohydrate	59	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	14
Fluticasone Propionate	Fluticasone Propionate	54	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	16
Hydroxyzine Hcl	Hydroxyzine Hcl	47	13
Tamsulosin Hcl	Tamsulosin Hcl	46	14
Amitriptyline Hcl	Amitriptyline Hcl	44	14
Buspirone Hcl	Buspirone Hcl	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	31
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Atenolol	Atenolol	35	11
Alprazolam	Alprazolam	33	suppressed
Famotidine	Famotidine	33	14
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Cefuroxime	Cefuroxime Axetil	28	23
Farxiga	Dapagliflozin Propanediol	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Meloxicam	Meloxicam	27	11
Warfarin Sodium	Warfarin Sodium	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Cephalexin	Cephalexin	24	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Finasteride	Finasteride	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Glipizide	Glipizide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Ozempic	Semaglutide	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Nystatin	Nystatin	17	15
Primidone	Primidone	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Bupropion Xl	Bupropion Hcl	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fluconazole	Fluconazole	13	11
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cialis	Tadalafil	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Estradiol	Estradiol	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Codeine Sulfate	Codeine Sulfate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error